Insight Molecular Diagnostics (IMDX) Asset Utilization Ratio (2020 - 2026)

Insight Molecular Diagnostics (IMDX) has 7 years of Asset Utilization Ratio data on file, last reported at 0.06 in Q1 2026.

• Quarterly Asset Utilization Ratio fell 26.86% year-over-year to 0.06 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.06 (down 26.86% YoY) and the FY2025 annual result came in at 0.13, up 289.69% from the prior year.
• Asset Utilization Ratio retreated to 0.06 in Q1 2026 per IMDX's latest filing, from 0.12 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.12 in Q4 2025, with the low at 0.01 in Q4 2022.
• Average Asset Utilization Ratio over 5 years is 0.04, with a median of 0.03 recorded in 2022.
• Year-over-year, Asset Utilization Ratio slumped 84.21% in 2022 and jumped 852.71% in 2025.
• Insight Molecular Diagnostics' Asset Utilization Ratio stood at 0.01 in 2022, then soared by 158.11% to 0.02 in 2023, then jumped by 85.98% to 0.04 in 2024, then surged by 225.71% to 0.12 in 2025, then tumbled by 49.39% to 0.06 in 2026.
• Business Quant data shows IMDX's Asset Utilization Ratio at 0.06 in Q1 2026, 0.12 in Q4 2025, and 0.09 in Q3 2025.